These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15470768)

  • 1. Protease inhibitors and risk of developing HIV-related sensory neuropathy.
    Crabb C
    AIDS; 2004 Sep; 18(14):N10. PubMed ID: 15470768
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral drugs and the risk of myocardial infarction.
    Pollack TM; Rind DM
    N Engl J Med; 2007 Aug; 357(7):716; author reply 716-7. PubMed ID: 17703531
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral drugs and the risk of myocardial infarction.
    Kaplan RC; Tien PC; Lazar J
    N Engl J Med; 2007 Aug; 357(7):715; author reply 716-7. PubMed ID: 17699825
    [No Abstract]   [Full Text] [Related]  

  • 5. Side effects. The usual suspects.
    TreatmentUpdate; 2002 Nov; 14(8):1-2. PubMed ID: 12501819
    [No Abstract]   [Full Text] [Related]  

  • 6. No nukes please.
    TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501825
    [No Abstract]   [Full Text] [Related]  

  • 7. Report from the 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
    Confrancesco J
    Hopkins HIV Rep; 2003 Jan; 15(1):4-5. PubMed ID: 12542003
    [No Abstract]   [Full Text] [Related]  

  • 8. Focus on fat.
    TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral neuropathy: zalcitabine reassessed.
    Carey P
    Int J STD AIDS; 2000 Jul; 11(7):417-23. PubMed ID: 10919481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New HIV guidelines offer adverse effects data.
    AIDS Alert; 2002 Jul; 17(7):89-91. PubMed ID: 12116974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipodystrophy--introduction.
    TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity profile of HAART.
    TreatmentUpdate; 2001; 13(7):6-7. PubMed ID: 11794864
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.
    Brinkman K; Smeitink JA; Romijn JA; Reiss P
    Lancet; 1999 Sep; 354(9184):1112-5. PubMed ID: 10509516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Damage to the power plant.
    TreatmentUpdate; 2002 Mar; 14(3):1-2. PubMed ID: 12033185
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma carnitine in HIV-associated neuropathy.
    Simpson DM; Katzenstein D; Haidich B; Millington D; Yiannoutsos C; Schifitto G; McArthur J;
    AIDS; 2001 Nov; 15(16):2207-8. PubMed ID: 11684949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiretroviral treatment for HIV and adipose tissue].
    Caron M; Bastard JP; Auclair M; Vigouroux C; Capeau J
    Journ Annu Diabetol Hotel Dieu; 2003; ():147-58. PubMed ID: 12868307
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
    Cepeda JA; Wilks D
    AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteopenia in HIV infection.
    Carr A
    AIDS Clin Care; 2001 Aug; 13(8):71-3, 78. PubMed ID: 11547460
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of HIV-associated lipodystrophy.
    Wanke C
    AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.